1. Home
  2. PRLB vs BCRX Comparison

PRLB vs BCRX Comparison

Compare PRLB & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Proto Labs Inc.

PRLB

Proto Labs Inc.

HOLD

Current Price

$89.76

Market Cap

2.0B

Sector

Industrials

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.78

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRLB
BCRX
Founded
1999
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
2011
1995

Fundamental Metrics

Financial Performance
Metric
PRLB
BCRX
Price
$89.76
$8.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
11
Target Price
$53.00
$20.82
AVG Volume (30 Days)
148.3K
3.7M
Earning Date
05-01-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
381.40
EPS
0.71
N/A
Revenue
N/A
$25,186,000.00
Revenue This Year
$8.56
N/A
Revenue Next Year
$6.89
$12.55
P/E Ratio
$123.49
N/A
Revenue Growth
N/A
N/A
52 Week Low
$45.10
$6.00
52 Week High
$93.00
$11.22

Technical Indicators

Market Signals
Indicator
PRLB
BCRX
Relative Strength Index (RSI) 63.96 46.31
Support Level $77.11 $8.79
Resistance Level $93.00 $9.31
Average True Range (ATR) 2.29 0.32
MACD 0.99 -0.02
Stochastic Oscillator 87.30 40.04

Price Performance

Historical Comparison
PRLB
BCRX

About PRLB Proto Labs Inc.

Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. The Lab uses injection molding, computer numerical control machining, and 3-D printing, and sheet metal to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: